Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.

Mathurin P, Mendenhall CL, Carithers RL Jr, Ramond MJ, Maddrey WC, Garstide P, Rueff B, Naveau S, Chaput JC, Poynard T.

J Hepatol. 2002 Apr;36(4):480-7.

PMID:
11943418
2.

A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis.

Stewart S, Prince M, Bassendine M, Hudson M, James O, Jones D, Record C, Day CP.

J Hepatol. 2007 Aug;47(2):277-83.

PMID:
17532088
3.

Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial.

Carithers RL Jr, Herlong HF, Diehl AM, Shaw EW, Combes B, Fallon HJ, Maddrey WC.

Ann Intern Med. 1989 May 1;110(9):685-90.

PMID:
2648927
4.

Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.

Sharma P, Kumar A, Sharma BC, Sarin SK.

J Hepatol. 2009 Mar;50(3):584-91. doi: 10.1016/j.jhep.2008.10.024.

PMID:
19155081
5.

Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids.

Louvet A, Diaz E, Dharancy S, Coevoet H, Texier F, Thévenot T, Deltenre P, Canva V, Plane C, Mathurin P.

J Hepatol. 2008 Mar;48(3):465-70. doi: 10.1016/j.jhep.2007.10.010.

PMID:
18164508
6.

A randomized trial of prednisolone in patients with severe alcoholic hepatitis.

Ramond MJ, Poynard T, Rueff B, Mathurin P, Théodore C, Chaput JC, Benhamou JP.

N Engl J Med. 1992 Feb 20;326(8):507-12.

7.

Invasive aspergillosis in patients with severe alcoholic hepatitis.

Gustot T, Maillart E, Bocci M, Surin R, Trépo E, Degré D, Lucidi V, Taccone FS, Delforge ML, Vincent JL, Donckier V, Jacobs F, Moreno C.

J Hepatol. 2014 Feb;60(2):267-74. doi: 10.1016/j.jhep.2013.09.011.

PMID:
24055548
8.

Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial).

Sidhu SS, Goyal O, Singla P, Gupta D, Sood A, Chhina RS, Soni RK.

Dig Dis Sci. 2012 Jun;57(6):1664-71. doi: 10.1007/s10620-012-2097-4.

PMID:
22388710
9.

The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.

Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, Dharancy S, Texier F, Hollebecque A, Serfaty L, Boleslawski E, Deltenre P, Canva V, Pruvot FR, Mathurin P.

Hepatology. 2007 Jun;45(6):1348-54.

PMID:
17518367
10.

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data.

Mathurin P, O'Grady J, Carithers RL, Phillips M, Louvet A, Mendenhall CL, Ramond MJ, Naveau S, Maddrey WC, Morgan TR.

Gut. 2011 Feb;60(2):255-60. doi: 10.1136/gut.2010.224097.

PMID:
20940288
11.

The amount of alcohol consumption negatively impacts short-term mortality in Mexican patients with alcoholic hepatitis.

Altamirano J, Higuera-de laTijera F, Duarte-Rojo A, Martínez-Vázquez MA, Abraldes JG, Herrera-Jiménez LE, Michelena J, Zapata L, Perez-Hernández J, Torre A, Gonzáles-González JA, Cardenas A, Dominguez M, Arroyo V, Ginès P, Caballería J, Bataller R.

Am J Gastroenterol. 2011 Aug;106(8):1472-80. doi: 10.1038/ajg.2011.141.

PMID:
21556041
12.

Corticosteroids or non-corticosteroids: a fresh perspective on alcoholic hepatitis treatment.

Wang F, Wang BY.

Hepatobiliary Pancreat Dis Int. 2011 Oct;10(5):458-64. Review.

13.

Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.

Louvet A, Wartel F, Castel H, Dharancy S, Hollebecque A, Canva-Delcambre V, Deltenre P, Mathurin P.

Gastroenterology. 2009 Aug;137(2):541-8. doi: 10.1053/j.gastro.2009.04.062.

PMID:
19445945
14.

Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone.

Mathurin P, Abdelnour M, Ramond MJ, Carbonell N, Fartoux L, Serfaty L, Valla D, Poupon R, Chaput JC, Naveau S.

Hepatology. 2003 Dec;38(6):1363-9.

PMID:
14647046
15.

Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis.

Singh S, Murad MH, Chandar AK, Bongiorno CM, Singal AK, Atkinson SR, Thursz MR, Loomba R, Shah VH.

Gastroenterology. 2015 Oct;149(4):958-70.e12. doi: 10.1053/j.gastro.2015.06.006. Review.

PMID:
26091937
16.

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O.

Gastroenterology. 2000 Dec;119(6):1637-48.

PMID:
11113085
17.

Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials.

Imperiale TF, McCullough AJ.

Ann Intern Med. 1990 Aug 15;113(4):299-307.

PMID:
2142869
18.

The management of alcoholic hepatitis: a prospective comparison of scoring systems.

Lafferty H, Stanley AJ, Forrest EH.

Aliment Pharmacol Ther. 2013 Sep;38(6):603-10. doi: 10.1111/apt.12414.

19.

Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis.

Jalan R, Sen S, Steiner C, Kapoor D, Alisa A, Williams R.

J Hepatol. 2003 Jan;38(1):24-31.

PMID:
12480556
20.

Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: A population-based study.

Pang JX, Ross E, Borman MA, Zimmer S, Kaplan GG, Heitman SJ, Swain MG, Burak K, Quan H, Myers RP.

Can J Gastroenterol Hepatol. 2015 Apr;29(3):131-8.

Items per page

Supplemental Content

Support Center